Oncology

The Pharmacy Times® Oncology resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

What can we help you find?
[[thumbnail_alt_text]]
Because of the vulnerabilities of CDK4/6i-resistant tumors, researchers believe that it is imperative to improve the survival of this group of patients.
[[thumbnail_alt_text]]
The rise in value-based reimbursement models has required oncology care providers to assume an unprecedented level of accountability.
[[thumbnail_alt_text]]
The decline in the cancer mortality rate attributed to immunotherapy methods, early detection, and treatment.
[[thumbnail_alt_text]]
Maurie Markman, MD, leads a discussion on the design and results of the PRIMA trial, and how it has impacted practice.
[[thumbnail_alt_text]]
After injecting the flu vaccine into a tumor cell, researchers found that the injection either slowed the growth or shrunk the tumor itself.
[[thumbnail_alt_text]]
Key opinion leaders discuss the importance of HRD testing, with special consideration of tissue testing versus somatic testing.
[[thumbnail_alt_text]]
This medication is the first precision therapy approved to treat a genomically defined population of patients with GIST, according to Blueprint Medicines.
 
[[thumbnail_alt_text]]
Officials with the FDA have approved pembrolizumab (Keytruda, Merck) for the treatment of certain patients with Bacillus Calmette-Guerin-unresponsive, high-risk, non-muscle invasive bladder cancer.
[[thumbnail_alt_text]]
An effective treatment plan for squamous cell carcinoma best undertaken by a group of practitioners.
[[thumbnail_alt_text]]
Since 2004, the FDA has approved different treatments for advanced prostate cancer, adding almost 2-3 indications per year for the past 15 years.
[[thumbnail_alt_text]]
A study suggests that even brief art-making interventions can be beneficial for stressed caregivers of patients with cancer.
[[thumbnail_alt_text]]
According to the study authors, such “anti-austerity agents” represent a promising approach to cancer chemotherapy.